Capricor Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Capricor Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Capricor Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Capricor Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.4M | 190k | 7.21 |
| 2025-03-31 | $165k | 17k | 9.49 |
| 2024-12-31 | $230k | 17k | 13.80 |
| 2024-09-30 | $855k | 56k | 15.21 |
| 2024-06-30 | $52k | 11k | 4.77 |
| 2024-03-31 | $619k | 91k | 6.79 |
| 2020-09-30 | $30k | 5.6k | 5.35 |
| 2020-06-30 | $0 | 7 | 0.00 |